Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 20;13(2):e060106.
doi: 10.1136/bmjopen-2021-060106.

Examining the levels of psychological support available to patients with haematological cancer in England: a mixed methods study

Affiliations

Examining the levels of psychological support available to patients with haematological cancer in England: a mixed methods study

Jo Brett et al. BMJ Open. .

Abstract

Objectives: The psychological impact of a haematological malignancy is well documented. However, few studies have assessed the provision of psychological support to people with these diagnoses. This study explores the extent and nature of psychological support for people diagnosed with haematological cancer to inform future service provision.

Design: This study consisted of an online survey with healthcare professionals (phase 1) and qualitative interviews with patients (phase 2) and key health professionals (phase 3). A descriptive analysis of survey data and thematic analysis of interviews were conducted.

Participants: Two hundred health professionals practising in England completed the survey. Twenty-five interviews were conducted with people diagnosed with haematological cancer in the past 3 years, and 10 with key health professionals, including haematologists, cancer nurse specialists and psychologists were conducted.

Primary outcome measures: Level of psychological assessment undertaken with people with haematological cancer, and level and nature of psychological support provided.

Results: Less than half (47.3%) of survey respondents strongly agreed/agreed that their patients were well supported in terms of their psychological well-being and approximately half (49.4%) reported providing routine assessment of psychological needs of patients, most commonly at the time of diagnosis or relapse. Patients described their need for psychological support, their experiences of support from health professionals and their experiences of support from psychological therapy services. There was considerable variation in the support patients described receiving. Barriers to providing psychological support reported by health professionals included time, skills, resources and patient barriers. Most doctors (85%) and 40% of nurse respondents reported receiving no training for assessing and managing psychological needs.

Conclusions: Psychological well-being should be routinely assessed, and person-centred support should be offered regularly throughout the haematological cancer journey. Greater provision of healthcare professional training in this area and better integration of psychological support services into the patient care pathway are required.

Keywords: adult psychiatry; haematology; leukaemia; lymphoma; oncology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Blood cancer UK statistics on blood cancer. 2021. Available: http://bloodcancer.org.uk/understandingbloodcancer
    1. Sant M, Allemani C, Tereanu C, et al. . Incidence of hematologic malignancies in europe by morphologic subtype: results of the HAEMACARE project. Blood 2010;116:3724–34. 10.1182/blood-2010-05-282632 - DOI - PubMed
    1. Campo E, Swerdlow SH, Harris NL, et al. . The 2008 who classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011;117:5019–32. 10.1182/blood-2011-01-293050 - DOI - PMC - PubMed
    1. Engert A, Plütschow A, Eich HT, et al. . Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma. N Engl J Med 2010;363:640–52. 10.1056/NEJMoa1000067 - DOI - PubMed
    1. Bonifant CL, Jackson HJ, Brentjens RJ, et al. . Toxicity and management in CAR T-cell therapy. Mol Ther Oncolytics 2016;3:16011. 10.1038/mto.2016.11 - DOI - PMC - PubMed

Publication types

LinkOut - more resources